Physician profile
Amanda Chenault
NPI 1467141119
$1,202.71
in general payments reported to CMS, 2019-2025
8 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $283 · 2024: $467 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,203.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,202.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $712.87 | 2023-2025 | |
| Teva Pharmaceuticals USA, INC. | $179.35 | 2024-2025 | Uzedy, Austedo Xr, Austedo Xr |
| Dexcom, INC. | $136.12 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Indivior INC. | $54.04 | 2023 | Perseris |
| Janssen Pharmaceuticals, INC | $38.85 | 2023-2024 | Invega Sustenna, Invega Trinza |
| E.R. Squibb & Sons, L.L.C. | $34.74 | 2025 | Cobenfy |
| Neurocrine Biosciences, INC. | $31.24 | 2024 | Ingrezza |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $15.50 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Chenault listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.